Group 1 - The company is holding its second extraordinary general meeting of shareholders on September 12, 2025, to ensure the rights of all shareholders and maintain order during the meeting [1][3] - The meeting will include a combination of on-site and online voting, with results to be announced after the voting process [2][3] - Shareholders and their representatives have the right to speak, inquire, and vote during the meeting, but must adhere to the established rules and procedures [2][3] Group 2 - The company plans to terminate certain fundraising projects and allocate the remaining funds to new projects, specifically reallocating 68.2 million yuan to the "Changzhou Production Base Automation Upgrade Project" [6][7] - The decision to terminate these projects is based on changes in market conditions and the company's operational strategy, ensuring compliance with relevant laws and regulations [6][7] - The company will ensure the legal and effective use of the remaining funds and will not engage in related party transactions regarding this change in fundraising usage [7]

Summary of Key Points Core Viewpoint The report provides an overview of the fundraising activities and the utilization of funds by Zhejiang Fulai New Materials Co., Ltd. as of June 30, 2025, confirming compliance with regulatory requirements and detailing the financial status of previous fundraising efforts. Group 1: Fundraising Overview - The company raised a total of RMB 612.90 million from its initial public offering (IPO) in 2021, with a net amount of RMB 530.63 million after deducting underwriting fees and other expenses [4][5]. - In 2023, the company issued convertible bonds, raising RMB 429.02 million, with a net amount of RMB 415.95 million after expenses [6][9]. Group 2: Fund Utilization - As of June 30, 2025, the company has utilized RMB 504.07 million of the raised funds, with RMB 12.65 million remaining in bank accounts [5][10]. - The company temporarily used RMB 50 million of idle funds to supplement working capital [20][24]. Group 3: Changes in Fund Allocation - The company approved changes to the allocation of funds for the "Functional Coating Composite Material Production Base and R&D Center Headquarters" project, reallocating 37.69% of the total funds raised [11]. - The company also transferred assets and liabilities from its subsidiary to optimize its organizational structure and improve operational efficiency [12]. Group 4: Financial Performance and Returns - The company reported a total interest income and returns from structured deposits amounting to RMB 2.47 million from the IPO funds [5][10]. - The actual investment in the "New Environmental Pre-coating Functional Material Construction Project" was RMB 31.23 million, which is lower than the committed amount due to market conditions and project delays [15][18]. Group 5: Idle Fund Management - The company has engaged in cash management by investing idle funds in low-risk, short-term financial products, achieving returns of RMB 1.06 million in 2021 and RMB 0.166 million in 2022 [20][22]. - As of June 30, 2025, all structured deposit products purchased with idle funds have been redeemed [25].

Fundraising and Storage Situation - The company raised a total of RMB 61,290.00 million from its initial public offering (IPO) in 2021, with a net amount of RMB 53,063.13 million after deducting fees [1][2] - As of June 30, 2025, the remaining balance of the previous fundraising is RMB 126.49 million, with RMB 5,000.00 million used for working capital [1][2] - The company raised RMB 42,901.80 million from the issuance of convertible bonds in 2023, with a net amount of RMB 41,589.49 million after deducting fees [1][2] Fund Usage - The company has utilized RMB 50,406.72 million of the funds raised from the 2021 IPO, with a remaining balance of RMB 5,126.49 million, accounting for 9.66% of the net amount [1][12] - The company plans to continue using the remaining funds for investment projects [12] - The company has used RMB 31,225.80 million of the funds raised from the 2023 convertible bond issuance, with a remaining balance of RMB 11,747.47 million, accounting for 28.25% of the net amount [12] Changes in Fund Usage - The company has approved a change in the use of RMB 20,000.00 million from the 2021 IPO funds to invest in a new materials project in Yantai, which represents 37.69% of the total funds raised [1][2] - The company has also approved changes to the implementation location and extended the deadline for the "New Environmental Pre-coating Functional Materials Construction Project" funded by the 2023 convertible bonds [1][2] Investment Efficiency and Returns - The actual investment amount for the "Functional Coating Composite Material Production Base and R&D Center Headquarters" project is RMB 50,406.72 million, with a shortfall of RMB 2,656.41 million compared to the committed amount due to interest income and bank fees [5] - The "New Environmental Pre-coating Functional Materials Construction Project" has an actual investment of RMB 31,225.80 million, with a shortfall of RMB 10,363.69 million as the project is still under construction [5] Idle Fund Management - The company has used idle funds from the 2021 IPO to temporarily supplement working capital, amounting to RMB 5,000 million [7][10] - The company has also engaged in financial management of idle funds, purchasing low-risk, short-term financial products, with a total of RMB 53,500.00 million in structured deposits and RMB 1,064.91 million in returns in 2021 [8][9]

Core Viewpoint - The report provides a detailed account of the fundraising activities and the usage of funds by 博瑞生物医药 (Suzhou) Co., Ltd. as of June 30, 2025, highlighting the amounts raised, their allocation, and the management of these funds [1][2][3]. Fundraising Overview - The company raised a total of RMB 521.11 million from its initial public offering (IPO) in 2019, with a net amount of RMB 439.98 million after deducting various fees [1]. - In 2022, the company issued convertible bonds amounting to RMB 465 million, resulting in a net amount of RMB 456.83 million after fees [2]. - The company also raised RMB 226.61 million through a private placement of shares in November 2022, with the net amount after fees not specified [2]. Fund Management - The company established a dedicated account for managing the raised funds, ensuring that the funds are used specifically for their intended purposes [3]. - A tripartite supervision agreement was signed with the underwriter and banks to oversee the management of the funds [3]. Fund Usage and Balance - As of June 30, 2025, the total amount of funds used from the IPO was RMB 455.75 million, with a remaining balance of RMB 0.00 million [5]. - For the convertible bonds, RMB 466.75 million was used, leaving no remaining balance [5]. - From the private placement, RMB 188.74 million was utilized, with a remaining balance of RMB 3.64 million [13]. Project Adjustments - The company did not make any adjustments to the investment amounts for the projects funded by the IPO as of June 30, 2025 [5]. - The overseas high-end formulation drug production project was delayed, with the expected completion date pushed from December 2021 to June 2023 due to various factors including the pandemic [5]. - The company has also changed the implementation entities for some projects to improve management efficiency [5]. Temporary Idle Funds - The company has not used idle funds to temporarily supplement working capital as of June 30, 2025 [8]. - The company has engaged in cash management for temporarily idle funds, generating a total return of RMB 15.62 million from such activities [10][12].

Core Points - The report details the fundraising and usage status of Matsui New Materials Group Co., Ltd. for the first half of 2025, confirming compliance with regulatory requirements and accurate disclosures [1][6][8] Fundraising Overview - The total amount raised from the public offering was RMB 686,152,000, with 1,990,000 shares issued at a price of RMB 34.48 per share [1][2] - After deducting underwriting and related fees totaling RMB 51,760,236.35, the net proceeds amounted to RMB 634,391,763.65, which was fully deposited into a designated account on June 2, 2020 [1][2] Fund Usage and Surplus - As of June 30, 2025, the company had invested RMB 407,116,710.56 into fundraising projects and used RMB 118,000,000 of over-raised funds to permanently supplement working capital [1][3] - The remaining balance of unused fundraising was RMB 149,295,240.96, with RMB 30,000,000 allocated to financial products [2][3] Fund Management - The company established a fundraising management system to ensure efficient use and protection of investor rights, including opening special accounts for fundraising [1][2] - A tripartite supervision agreement was signed with several banks and the underwriting institution to clarify responsibilities and obligations regarding the management of the funds [1][2] Cash Management - The company has utilized temporarily idle fundraising for cash management, with a maximum limit of RMB 580,000,000 approved for investment in low-risk financial products [2][3] - As of June 30, 2025, the balance of idle funds under cash management was RMB 30,000,000, invested in structured deposits [3][4] Use of Over-raised Funds - The company has used RMB 59,000,000 of over-raised funds for permanent working capital supplementation, approved by the board and shareholders [3][4] - The remaining over-raised funds were also allocated for similar purposes without affecting the funding needs of investment projects [4][7] Project Adjustments - The company has made adjustments to the investment amounts and timelines for certain fundraising projects to enhance efficiency and adapt to market conditions [4][7] - The total planned investment for adjusted projects increased by RMB 84,012,500, funded entirely by over-raised funds [4][7] Surplus Fund Usage - The company reported a surplus of RMB 91,724,400 as of December 31, 2024, due to cost savings from improved operational efficiencies and strategic procurement decisions [7][8] - The surplus funds will be allocated to new projects and permanent working capital, as approved by the board and shareholders [7][8]

Summary of Key Points Core Viewpoint The report outlines the fundraising activities and the subsequent changes in investment projects of Guangdong Dongfeng New Materials Group Co., Ltd. It details the amount raised, the allocation of funds, and the adjustments made to the original investment projects. Group 1: Fundraising Overview - The company raised a total of RMB 1,219,999,999.92 through a non-public issuance of A-shares, with a net amount of RMB 1,200,138,342.55 after deducting issuance costs [2][5] - The funds were deposited in a special account, and a tripartite supervision agreement was signed to oversee the use of these funds [2][3] Group 2: Changes in Investment Projects - The original project "Hunan Furu High-end Packaging Printing Intelligent Factory Renovation and Relocation Project" had a total investment of RMB 73,016.13 million, with RMB 25,803.90 million utilized as of September 21, 2023 [3][4] - The project has been changed to "Dongfeng Shoujian Annual Production of 6.5 Billion Pharmaceutical Glass Bottles Production Base Project" and "Yancheng Bosheng Lithium Battery Diaphragm Production Project (Phase II)" [4][5] Group 3: Fund Allocation and Usage - The remaining funds from the original project amounted to RMB 48,660.24 million, which includes RMB 47,212.23 million in principal and RMB 1,448.01 million in net interest income [3][4] - The company has allocated RMB 42,004.86 million for the new glass bottle production project and RMB 32,459.28 million for the lithium battery diaphragm project [4][10] Group 4: Fund Management - The company has established a fundraising management system to ensure the proper use and security of the funds, adhering to relevant laws and regulations [6][8] - The company has signed various agreements to manage the funds effectively, including terminating agreements for projects that are no longer proceeding [6][8]

Summary of Key Points Core Viewpoint The report provides a detailed account of Nanjing Guanshi Technology Co., Ltd.'s fundraising activities, including the amount raised, its usage, and management practices, ensuring compliance with regulatory requirements and protecting investor interests. Group 1: Fundraising Overview - The company raised a total of RMB 501,100,500 through the issuance of 18,275,000 shares at RMB 27.42 per share, with net proceeds amounting to RMB 455,867,927.74 after deducting issuance costs [1][2][3] - As of June 30, 2025, the company has utilized RMB 380,779,938.44 of the raised funds, leaving a remaining balance of RMB 98,261,870.03 [1][2][3] - The total amount used in the first half of 2025 was RMB 118,935,655.08, with previous years accounting for RMB 261,844,283.36 [1][2][3] Group 2: Fund Management Practices - The company has established a fundraising management system in compliance with relevant laws and regulations, ensuring funds are stored in dedicated bank accounts [1][2][3] - A tripartite supervision agreement was signed with banks and the sponsor to regulate the use and storage of the funds, which has been strictly adhered to [1][2][3] - As of June 30, 2025, the company has canceled the fundraising accounts as per the regulatory requirements [1][2][3] Group 3: Fund Usage and Project Updates - The company has invested RMB 11,893.56 million in fundraising projects during the reporting period, with a cumulative investment of RMB 38,077.99 million [5][6][7] - A significant portion of the funds has been redirected to the "Photomask Manufacturing Project," with 56.27% of the total funds being reallocated due to market demand fluctuations [5][6][7] - The company has not encountered any issues with the use of funds, and all activities have been reported transparently [5][6][7]

Summary of Key Points Core Viewpoint The report outlines the fundraising activities and the management of raised funds by Wuhan Yangtze Communication Industry Group Co., Ltd. for the first half of 2025, detailing the amount raised, its usage, and the management protocols in place to ensure compliance with regulatory requirements. Fundraising Overview - The company raised a total of RMB 649,999,990.52 through the issuance of 51,505,546 shares at a price of RMB 12.62 per share, after deducting issuance costs of RMB 6,425,445.80, resulting in a net amount of RMB 643,574,544.72 [1][2]. - The funds were verified by an accounting firm and a verification report was issued on December 19, 2023 [1]. Fund Usage and Balance - As of June 30, 2025, the balance in the dedicated fundraising account was RMB 2,344,417.40 after accounting for various deductions and additions, including cash management income [1][2]. - Cumulative investments from the raised funds amounted to RMB 71,894,318.53, with a permanent fund replenishment of RMB 1,853,928.41 [1][2]. Fund Management Protocols - The company has established a fundraising management system to ensure the proper use and security of the funds, adhering to relevant laws and regulations [1][2]. - A tripartite supervision agreement was signed with the bank to manage the dedicated fundraising account [1][2]. Investment Project Status - The company has not used idle funds for temporary liquidity needs during the reporting period [2]. - The company has approved the use of idle funds for cash management, with a maximum of RMB 586 million allocated for safe and liquid financial products [2][4]. Changes in Investment Projects - The company has decided to postpone the completion date for the "Smart Emergency Command Product Upgrade and Industrialization Project" to December 2030 due to land use rights issues [5][6]. - Adjustments were made to the investment scale and structure of several projects, including the "Marketing Network Construction Project" and "Next Generation Smart Emergency Digital Transformation Key Technology Research Project" [5][6]. Other Fund Usage Situations - The company has not used excess funds for permanent liquidity replenishment or to repay bank loans during the reporting period [4][5]. - The company has reported no violations in the management and disclosure of fundraising activities [6].

Core Viewpoint - The company, Kunshan Guoli Electronics Technology Co., Ltd., has announced a change in the investment projects funded by its convertible bonds, reallocating funds from a solar-related project to a new high-end electronic vacuum device manufacturing expansion project due to underperformance in the original sector [1][2]. Group 1: Company Announcement - The company has reduced the funding for the original project "Production of AC Contactors for Wind and Solar Storage and Flexible Direct Current Transmission" from 200 million yuan to 57.5 million yuan [1]. - The new project, "Expansion of Intelligent Manufacturing for High-end Electronic Vacuum Devices and Integrated Systems," is expected to be completed by 2027 and will utilize the adjusted funds [1]. - The decision to change the investment focus is attributed to lower-than-expected demand in the photovoltaic upstream equipment sector and increased competition affecting product pricing and profit margins [1]. Group 2: Financial Ratings - The credit rating agency, Zhongzheng Pengyuan, has maintained the company's credit rating at A+ with a stable outlook, reflecting confidence in the company's financial health despite the project changes [2]. - The credit rating for the convertible bond, "Guoli Convertible Bond," remains at A+, valid until August 27, 2025 [2]. - The agency will continue to monitor the construction, production, and future revenue of the new investment project to assess its impact on the company's credit rating [2].

Core Viewpoint - The company, Xi'an Pairui Power Semiconductor Technology Co., Ltd., is adjusting its fundraising project by changing part of the construction content, project location, and extending the implementation period due to market conditions and operational considerations [2][9]. Fundraising Project Adjustment Overview - The company raised a total of RMB 318.4 million by issuing 80 million shares at RMB 3.98 per share, with a net amount of RMB 269.31 million after deducting issuance costs [1]. - The adjustments were approved in meetings held on January 17, 2024, and February 2, 2024, and will be submitted for shareholder approval [2][8]. Original and Adjusted Project Details - The original project was focused on the industrialization of high-power semiconductor devices, with a total planned investment of RMB 57 million, using RMB 26.93 million from the raised funds [4][6]. - The adjusted project will now focus on 5-inch and 6-inch thyristors, IGCT, FRD, and other power semiconductor modules, with a revised total investment of RMB 53.53 million, maintaining the use of RMB 26.93 million from the raised funds [7][4]. Reasons for Adjustment - The company identified intense competition in the SiC market, dominated by international firms, leading to the decision to cancel SiC-related R&D and production plans due to high investment costs and limited market entry channels [6][3]. - The adjustments are deemed necessary to align with market conditions and the company's strategic development, aiming to reduce investment risks and protect shareholder interests [9][8]. Review and Approval Process - The adjustments have been reviewed and approved by the company's board and supervisory committee, and are pending approval from the shareholders [9][8]. - The sponsor institution, China International Capital Corporation, has confirmed that the adjustments comply with relevant regulations and do not harm shareholder interests [9].